Insufficient sleep during adolescence and risk of multiple sclerosis: results from a Swedish case-control study.


Journal

Journal of neurology, neurosurgery, and psychiatry
ISSN: 1468-330X
Titre abrégé: J Neurol Neurosurg Psychiatry
Pays: England
ID NLM: 2985191R

Informations de publication

Date de publication:
05 2023
Historique:
received: 16 08 2022
accepted: 04 12 2022
medline: 17 4 2023
pubmed: 24 1 2023
entrez: 23 1 2023
Statut: ppublish

Résumé

Shift work, which often results in sleep deprivation and circadian desynchrony, has been associated with increased risk of multiple sclerosis (MS). We aimed at studying the impact of sleep duration, circadian disruption and sleep quality on MS risk. We used a Swedish population-based case-control study (2075 cases, 3164 controls). Aspects of sleep were associated with MS risk by calculating OR with 95% CIs using logistic regression models. Compared with sleeping 7-9 hours/night during adolescence, short sleep (<7 hours/night) was associated with increased risk of developing MS (OR 1.4, 95% OR 1.1-1.7). Similarly, subjective low sleep quality during adolescence increased the risk of subsequently developing MS (OR 1.5, 95% CI 1.3 to 1.9), whereas phase shift did not significantly influence the risk. Our findings remained similar when those who worked shifts were excluded. Insufficient sleep and low sleep quality during adolescence seem to increase the risk of subsequently developing MS. Sufficient restorative sleep at young age, needed for adequate immune functioning, may be a preventive factor against MS.

Sections du résumé

BACKGROUND
Shift work, which often results in sleep deprivation and circadian desynchrony, has been associated with increased risk of multiple sclerosis (MS). We aimed at studying the impact of sleep duration, circadian disruption and sleep quality on MS risk.
METHODS
We used a Swedish population-based case-control study (2075 cases, 3164 controls). Aspects of sleep were associated with MS risk by calculating OR with 95% CIs using logistic regression models.
RESULTS
Compared with sleeping 7-9 hours/night during adolescence, short sleep (<7 hours/night) was associated with increased risk of developing MS (OR 1.4, 95% OR 1.1-1.7). Similarly, subjective low sleep quality during adolescence increased the risk of subsequently developing MS (OR 1.5, 95% CI 1.3 to 1.9), whereas phase shift did not significantly influence the risk. Our findings remained similar when those who worked shifts were excluded.
CONCLUSIONS
Insufficient sleep and low sleep quality during adolescence seem to increase the risk of subsequently developing MS. Sufficient restorative sleep at young age, needed for adequate immune functioning, may be a preventive factor against MS.

Identifiants

pubmed: 36690431
pii: jnnp-2022-330123
doi: 10.1136/jnnp-2022-330123
pmc: PMC10176406
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

331-336

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: TÅ has been supported by Tercentenary fund of Bank of Sweden, AFA Insurance and European Aviation Safety Authority. LA reports grants from Swedish Research Council, grants from Swedish Research Council for Health Working Life and Welfare, grants from Swedish Brain Foundation, during the conduct of the study; personal fees from Teva, personal fees from Biogene Idec, outside the submitted work. TO has received lecture/advisory board honoraria, and unrestricted MS research grants from Biogen, Novartis, Sanofi and Merck.

Références

J Immunol. 2010 Nov 15;185(10):5796-805
pubmed: 20944004
J Sleep Res. 2003 Mar;12(1):1-12
pubmed: 12603781
Clin Exp Immunol. 2009 Feb;155(2):231-8
pubmed: 19040608
Sports (Basel). 2018 May 10;6(2):
pubmed: 29910346
Mult Scler. 2015 Aug;21(9):1195-9
pubmed: 25698167
Gerontology. 2010;56(6):574-80
pubmed: 20130392
Mult Scler Relat Disord. 2016 Sep;9:104-9
pubmed: 27645354
Brain Behav Immun. 2018 Mar;69:154-166
pubmed: 29154957
Int J Environ Res Public Health. 2021 Jan 18;18(2):
pubmed: 33477410
Chronobiol Int. 2008 Apr;25(2):333-48
pubmed: 18484368
Acta Paediatr. 2018 Apr;107(4):694-700
pubmed: 29363166
Nat Sci Sleep. 2021 Feb 16;13:201-207
pubmed: 33623461
J Adolesc. 2016 Aug;51:41-9
pubmed: 27294324
Prev Med. 2016 Apr;85:36-41
pubmed: 26791323
PLoS One. 2015 Feb 25;10(2):e0118467
pubmed: 25714703
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Commun Biol. 2021 Nov 18;4(1):1304
pubmed: 34795404
BMJ Open. 2019 Oct 22;9(9):e031161
pubmed: 31641035
PLoS One. 2009;4(2):e4589
pubmed: 19240794
Ann Neurol. 2011 Nov;70(5):733-41
pubmed: 22006815
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Sleep Med. 2013 Mar;14(3):229-36
pubmed: 23352029
Mol Cell Biochem. 2018 Dec;449(1-2):63-72
pubmed: 29549603
Curr Biol. 2004 Dec 29;14(24):R1038-9
pubmed: 15620633
Inf Commun Soc. 2018;21(2):163-173
pubmed: 29628784
Front Immunol. 2019 Oct 29;10:2546
pubmed: 31736967
Sleep. 2015 Apr 01;38(4):581-6
pubmed: 25669189
Sleep Med. 2011 Feb;12(2):110-8
pubmed: 21257344

Auteurs

Torbjörn Åkerstedt (T)

Stress Research, Stockholm University, Stockholm, Sweden.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Tomas Olsson (T)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Karolinska University Hospital, Stockholm, Sweden.

Lars Alfredsson (L)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Center for Occupational and Environmental Medicine, Region Stockholm, Stockholm, Sweden.
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Anna Karin Hedström (AK)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden anna.hedstrom@ki.se.
Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH